# OnCo record nct02521493 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct02521493/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct02521493", "NCT02521493" ;
  schema:name "Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome"@en ;
  schema:description "A phase 3 trial of Asparaginase, Crisantaspase, Cytarabine, Daunorubicin, Etoposide, Mitoxantrone and Thioguanine in Acute myeloid leukaemia and Leukaemia, run by Children's Oncology Group, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct02521493/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02521493> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/leukaemia/> ;
  onco:drugs <https://onco.cc/drugs/asparaginase/>, <https://onco.cc/drugs/crisantaspase/>, <https://onco.cc/drugs/cytarabine/>, <https://onco.cc/drugs/daunorubicin/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/mitoxantrone/>, <https://onco.cc/drugs/thioguanine/> .